# LB Pharmaceuticals Inc: Form SCHEDULE 13D, filed Sep 19, 2025

- Company: [LB Pharmaceuticals Inc](/companies/lbrx.md) (CIK 1691082)
- Form: SCHEDULE 13D
- Filed: 2025-09-19
- Accepted by EDGAR: Sep 19, 2025, 16:30 ET
- Period: not reported
- Accession: 0001193125-25-209153
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1691082/000119312525209153/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1691082/000119312525209153/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1691082/000119312525209153/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Sep 19, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-209153. Last ingested by Listed: Nov 5, 2026, 18:54 ET. No prices; not investment advice.